Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

CRBP US Equity

Corbus Pharmaceuticals Holdings, Inc.Health Care · Pharmaceutical Preparations · CIK 1595097 · FY ends Dec 31
$9.99
-0.09 (-0.89%)
USD · as of 2026-08-19 · marketstack
2 8-K filings · 0 13D · 2 13G
DateEventWhat happened / filerSource
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by CITADEL ADVISORS LLCsec.gov ↗
2026-08-068-K 7.01Regulation FD disclosuresec.gov ↗
2026-08-068-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-2713GSchedule 13G filed — ≥5% beneficial owner (passive) · by BlackRock, Inc.sec.gov ↗
2026-07-068-K 7.01Regulation FD disclosuresec.gov ↗
2026-07-068-K 1.01Entry into a material definitive agreementsec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-06

Every row is a filed document, checked against its EDGAR index.